260976-22-5

Upstream product

• 642-38-6 quebrachitol 
• 58769-23-6 1L-3,4,:5,6-di-O-isopropylidene-2-O-methyl-chiro-inositol 
• 134182-86-8 Methanesulfonic acid (3aS,4S,5S,5aS,8aR,8bS)-5-methoxy-2,2,7,7-tetramethyl-hexahydro-benzo[1,2-d;3,4-d']bis[1,3]dioxol-4-yl ester 
• 192068-51-2 Methanesulfonic acid (1R,2S,3S,4S,5R,6S)-2,3,4,5,6-pentahydroxy-cyclohexyl ester 
• 156672-20-7 Methanesulfonic acid (3aS,4S,5S,5aS,8aR,8bS)-5-hydroxy-2,2,7,7-tetramethyl-hexahydro-benzo[1,2-d;3,4-d']bis[1,3]dioxol-4-yl ester 
• 260976-21-4 (3aR,4S,5R,5aS,8aR,8bR)-5-(4-Methoxy-benzyloxy)-2,2,7,7-tetramethyl-hexahydro-benzo[1,2-d;3,4-d']bis[1,3]dioxol-4-ol 

Downstream Products

• 260976-23-6 (3aS,4R,5R,5aR,8aR,8bR)-4,5-Bis-(4-methoxy-benzyloxy)-2,2,7,7-tetramethyl-hexahydro-benzo[1,2-d;3,4-d']bis[1,3]dioxole 
• 116180-58-6 (1S,2R,3S,4R,5R,6S)-3,4-Bis-benzyloxy-5,6-bis-(4-methoxy-benzyloxy)-cyclohexane-1,2-diol 
• 187980-19-4 1D-1-O-allyl-2,5,6-tri-O-benzyl-3,4-di-O-p-methoxybenzyl-myo-inositol 
• 187980-39-8 (1S,2S,3R,4S,5S,6S)-2,3,6-Tris-benzyloxy-4,5-bis-(4-methoxy-benzyloxy)-cyclohexanol 
• 1055041-92-3 Diisopropyl-phosphoramidous acid benzyl ester (1S,2R,3S,4S,5R,6R)-2,3,6-tris-benzyloxy-4,5-bis-(4-methoxy-benzyloxy)-cyclohexyl ester 
• 671192-99-7 C₂₄H₃₀O₇ 

Relevant academic research and scientific papers

AKT INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF

Disclosed are inhibitors of the serine/threonine kinase Akt, pharmaceutical compositions comprising such inhibitors, and a method of preventing or treating a disease or condition in an animal by the use of such inhibitors. The Akt inhibitors have the form

A versatile approach to PI(3,4)P2, PI(4,5)P2, and PI(3,4,5)P3 from L-(-)-Quebrachitol

(matrix presented) PI(3,4)P2 R1 = R2 = PO3H2, R3 = H ; L-(-)-quebrachitol PI(4,5)P2 R1 = H, R2 = R3 = PO3H2 ; PI(3,4,5)Psu